Geralyn Lambert-Messerlian, Ph.D.

Associate Director, Prenatal and Special Testing
Associate Professor of Pathology
gmesserl@wihri.org
T: 401 453-7793
F: 401 276-7882

Women and Infants Hospital of Rhode Island
70 Elm Street
2nd floor
Providence RI 02903

Medical Education/Graduate Education:

Ph.D., Boston University, Behavioral Endocrinology

Fellowship:

Post-doc, Massachusetts General Hospital, Reproductive Endocrinology

Research Interests:

Inhibin, fertility, pregnancy

Current Approved Research Grants:
NIH – Inhibin/activin family in human craniofacial development - completed
NIH – First and second trimester evaluation of risk of aneuploidy (Down syndrome) - completed

Significant Publications:

Silver HM, Lambert-Messerlian GM, Reis FM, DiBlasio AM, Petraglia F, Canick JA. The mechanisms of increased maternal serum total activin A and inhibin A in preeclampsia. Journal of Society for Gynecologic Investigation, 9:308-12, 2002.

Lee T, LeShane ES, Messerlian GM, Canick JA, Farina A, Heber WW, Bianchi DW. Down syndrome and cell-free fetal DNA in archived maternal serum. American Journal of Obstetrics and Gynecology, 187:1217-21, 2002.

Thirunavukarasu PP, Lambert-Messerlian G, Robertson DM, Dawson G, Canick J, Wallace EM. Molecular weight forms of inhibin A, inhibin B and pro-alphaC in maternal serum, amniotic fluid and placental extracts of normal and Down syndrome pregnancies. Prenatal Diagnosis, 22(12):1086-92, 2002.